Google Search and YouTube revenues are projected to grow at 10% and 11%, respectively in Q4, showing slower growth compared ...

Is CyberArk overvalued despite recent growth from Venafi acquisition? Find out why it's rated as a Hold in this financial ...

The Finance Ghost explains how the tech conglomerate's resilience, AI strategy, and long-term growth potential make it his ...

New product launch teased for March 4 Thank you! Your transaction has been completed successfully. Sorry! Transaction failed. Please try again later. DATA SOURCES: Corporate data, historical price ...

While some AI stocks have skyrocketed over the last few years, not even Warren Buffett doubled his money every year when he ...

The ban could add 5 to 9 percent in Meta's earnings per share ... all your content eggs in one basket," Danielle Dullaghan, social strategy director, at the marketing agency Iris, told Business ...

Watch this special Budget 2025 coverage only on Business Today TV! BTTV brings you a new market show - 'Daily Calls,' where you can gain invaluable insights and clarity on your market queries ...

Sanofi confirms the expectation of a strong rebound in business EPS with growth at a low double-digit percentage at CER (before share buyback). 6 Sanofi intends to execute a share buyback program ...

6 Applying average January 2025 exchange rates, the currency impacts are estimated between +2% and +3% on sales and +2% and +3% on business EPS. 7 At CER ... in our website are provided solely for ...

Sanofi confirms the expectation of a strong rebound in business EPS with growth at a low double ... on our websites and newsletters. How we use your information depends on the product and service ...

Pharma launches up 56.5%, reaching sales of €0.8 billion, 8% of total sales, led by ALTUVIIIO Dupixent sales up 16.0% to €3.5 billion Vaccines sales up 10.8% to €2.2 billion, driven by Beyfortus sales ...

Q4: sales growth of 10.3% at CER 1 and business EPS 2 of €1.31 Pharma launches up 56.5%, reaching sales of €0.8 billion, 8% of total sales, led by ALTUVIIIO Dupixent sales up 16.0% to €3.5 ...